A holographic approach relying on small-molecule chromogens enables a rapid and inexpensive test for the accurate classification of aggressive lymphoma at the point of care.
This is a preview of subscription content, log in via an institution to check access.
References
Cancer factsheet go.nature.com/2MuHccB (World Health Organization, 2018).
Yager, P., Domingo, G. J. & Gerdes, J. Annu. Rev. Biomed. Eng. 10, 107–144 (2008).
Im, H. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-018-0265-3 (2018).
Im, H. et al. Proc. Natl Acad. Sci. USA 112, 5613–5618 (2015).
Pathania, D. et al. Theranostics 6, 1603–1610 (2016).
Saliba, A.-E. et al. Proc. Natl Acad. Sci. USA 107, 14524–14529 (2010).
Mitchell, P. S. et al. Proc. Natl Acad. Sci. USA 105, 10513–10518 (2008).
Lawrie, C. H. et al. Br. J. Haematol. 141, 672–675 (2008).
Hsieh, C.-H. et al. Sci. Rep. 8, 10684 (2018).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kopparthy, V.L., Snodgrass, R. & Erickson, D. Holographic diagnosis of lymphoma. Nat Biomed Eng 2, 631–632 (2018). https://doi.org/10.1038/s41551-018-0291-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-018-0291-1
- Springer Nature Limited